UBS: INNOVENT BIO (01801.HK) Upholds 2027 Sales Goal; Maintains Buy Rating
Investor Focus: During the 2026 Greater China Conference, investors concentrated on INNOVENT BIO's sales performance and R&D progress, particularly for its candidate IBI363 developed with Takeda Pharmaceutical.
Sales Confidence: INNOVENT BIO expressed confidence in achieving significant sales in 2025, targeting RMB20 billion in product sales by 2027, while also committing to advancing five candidates into global trials by 2030.
Market Analysis: UBS released a report rating INNOVENT BIO as a Buy, with a target price set at $137.4, reflecting optimism about the company's future performance.
Short Selling Data: The company experienced short selling of $231.31 million, with a short selling ratio of 19.38%, indicating some investor skepticism despite the positive outlook.
Discover Tomorrow's Bullish Stocks Today
Analyst Views on 01801
About the author
<Research>HSBC Identifies Hong Kong Stocks Receiving the Most Institutional Interest (Table)
Stock Performance Overview: Various stocks including AIA, Alibaba, and BYD showed mixed performance with AIA and Alibaba experiencing gains, while SMIC saw a decline.
Short Selling Data: Significant short selling activity was noted across multiple stocks, with BYD and SHK PPT having the highest short selling ratios at 34.941% and 35.602%, respectively.
Investment Ratings: Analysts have given "Buy" ratings to several companies including Alibaba, BOC Hong Kong, and Trip.com, while AIA is rated as "Hold."
Market Insights: JPMorgan estimates Alibaba's T-Head valuation to be between US$25-62 billion, indicating that a spinoff and separate listing is unlikely this year.
Guosen Securities Reveals Top 10 HK Stocks with Highest Foreign Capital Inflows and Outflows in Q4 2025 (Table)
Top Inflows: Guosen Securities reported the top ten Hong Kong stocks with the largest foreign capital inflows in 4Q25, led by INNOVENT BIO with an inflow of HKD6.43 billion.
Top Outflows: The report also highlighted the top ten stocks with the largest foreign capital outflows, with XIAOMI-W experiencing the highest outflow of HKD50.41 billion.
Short Selling Data: The report included short selling data for each stock, indicating significant short selling activity, particularly for XIAOMI-W and HSBC HOLDINGS.
Market Trends: The report reflects ongoing trends in the Hong Kong stock market, with notable shifts in foreign investment and short selling strategies among major companies.
